0
0

To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.

4/15/2026, 8:06 AM

Summary of Bill HR 8269

The bill titled "To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information" was introduced in the 119th Congress on April 14, 2026. The bill aims to modify the Federal Food, Drug, and Cosmetic Act to mandate drug labeling that discloses details of the original manufacturer and supply chain, potentially enhancing transparency and traceability in the pharmaceutical industry.

Current Status of Bill HR 8269

Bill HR 8269 is currently in the status of Bill Introduced since April 14, 2026. Bill HR 8269 was introduced during Congress 119 and was introduced to the House on April 14, 2026.  Bill HR 8269's most recent activity was Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of April 14, 2026

Bipartisan Support of Bill HR 8269

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8269

Primary Policy Focus

Alternate Title(s) of Bill HR 8269

To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.

Comments